Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Hypertension and SLCO1B3[original query] |
---|
Pharmacokinetics of bosentan in routinely treated Japanese pediatric patients with pulmonary arterial hypertension. Drug metabolism and pharmacokinetics 2011 Jun 26 (3): 280-7. Taguchi Masato, Ichida Fukiko, Hirono Keiichi, Miyawaki Toshio, Yoshimura Naoki, Nakamura Tsuneyuki, Akita Chisato, Nakayama Tomotaka, Saji Tsutomu, Kato Yuya, Horiuchi Isao, Hashimoto Yuki |
Association of CYP2C9*2 with bosentan-induced liver injury. Clinical pharmacology and therapeutics 2013 Dec 94 (6): 678-86. Markova S M, De Marco T, Bendjilali N, Kobashigawa E A, Mefford J, Sodhi J, Le H, Zhang C, Halladay J, Rettie A E, Khojasteh C, McGlothlin D, Wu A H B, Hsueh W-C, Witte J S, Schwartz J B, Kroetz D |
Effects of genetic variants in UGT1A1, SLCO1B3, ABCB1, ABCC2, ABCG2, ORM1 on PK/PD of telmisartan in Chinese patients with mild to moderate essential hypertension?. International journal of clinical pharmacology and therapeutics 2017 Aug 55 (8): 659-665. Pei Qi, Yang Liu, Tan Hong-Yi, Liu Shi-Kun, Liu Yang, Huang Lu, Li Rong-Hui, Wan Qian, Huang Jie, Guo Cheng-Xian, Zuo Xiao-Cong, Li Jingle, Yang Guo-Pi |
- Page last reviewed:Feb 1, 2024
- Content source: